Company: PSTV
Filing Date: 2025-08-04
Form Type: DRS
Source: 0000950123-25-006916
Chunk: 22

Company: PLUS THERAPEUTICS, INC.
Filing Date: 2025-08-04
Form: DRS
Chunk 22
---
-listing of our common stock from the Nasdaq Capital Market, our                                                                                                                                                                                 
 principal market, provided our common stock is not immediately thereafter trading on the New York Stock Exchange, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the NYSE American, the NYSE Arca, or the OTCQX 
 Best Market or the OTCQB Venture Market operated by OTC Markets Group Inc. (or nationally recognized successor thereto). See the discussion about compliance with Nasdaq listing standards at the bottom of this subsection “—Events of                
 Suspension.”                                                                                                                                                                                                                                           |

| • |     | The failure of our transfer agent to issue to Lincoln Park shares of our common stock within two business days 
 after the applicable date on which Lincoln Park is entitled to receive such shares of our common stock.        |

| • |     | Any breach of the representations or warranties or covenants contained in the Purchase Agreement or Registration                                                                            
 Rights Agreement that has or could have a material adverse effect on us and, in the case of a breach of a covenant that is reasonably curable, that is not cured within five business days. |

| • |     | Any voluntary or involuntary participation or threatened participation in insolvency or bankruptcy proceedings by 
 or against us.                                                                                                    |

| • |     | If at any time we are not eligible to transfer our common stock electronically. |

11

Confidential Treatment Requested by Plus Therapeutics, Inc. Pursuant to 17 C.F.R. Section 200.83

| • |     | If at any time the Exchange Cap (to the extent applicable under the terms of the Purchase Agreement) is reached                               
 and our stockholders have not approved the issuance of common stock in excess of the Exchange Cap in accordance with applicable Nasdaq rules. |

| • |     | if at any time Lincoln Park’s broker is unable to accept shares of our common stock issued under the 
 Purchase Agreement for deposit for reasons not within Lincoln Park’s control.                        |

Lincoln Park does not have the right to terminate the Purchase Agreement upon any of the events of suspension set forth above, although the Purchase Agreement would automatically terminate in the event of any voluntary or involuntary participation or threatened participation in insolvency or bankruptcy proceedings by or against us. During an event of suspension, all of which are outside of Lincoln Park’s control, we may not direct Lincoln Park to purchase any shares of our common stock under the Purchase Agreement. Our Termination Rights We have the unconditional right, at